ACTIVATED Probiotics has this month launched a new Biome Osteo Probiotic into the Australian pharmacy sector.
The company's CEO, Michael Oredsson, said the clinically trialled product reflected a "mounting body of research" which had uncovered an important role of the gut microbiota in the maintenance of bone health.
The study, published in The Lancet Rheumatology, found a significant reduction in bone loss (assessed at the lumbard spine) in women who received the probiotic product daily for 12 months, compared to those who received a placebo.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Nov 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Nov 19
